| Literature DB >> 33454381 |
Vishnu Priya Murali1, Christina A Holmes2.
Abstract
Extracellular vesicle (EV)- based therapies have been successfully tested in preclinical models for several biomedical applications, including tissue engineering, drug delivery and cancer therapy. However, EVs are most commonly delivered via local or systemic injection, which results in rapid clearance. In order to prolong the retention of EVs at target site and improve their therapeutic efficacy, biomaterial-based delivery systems are being investigated. This review discusses the various biomaterial-based systems that have been used to deliver EVs for therapeutic applications, specifically highlighting any strategies for controlled release. Further, challenges to clinical translation of biomaterial-based EV delivery systems are also discussed.Entities:
Keywords: Biomaterials; Drug delivery; Extracellular vesicles; Regenerative medicine; Tissue engineering
Mesh:
Substances:
Year: 2021 PMID: 33454381 DOI: 10.1016/j.actbio.2021.01.010
Source DB: PubMed Journal: Acta Biomater ISSN: 1742-7061 Impact factor: 8.947